Dracaena cinnabari
Dracaena cinnabari · Accepted scientific name
Scientific literature: Very Sparse (0 studies) · ★☆☆☆☆
Dracaena cinnabari is a unique botanical species known for producing a valuable gum resin. Scientific investigations into its chemical profile have identified key bioactive compounds, including flavonoids and 2,4'-dihydroxy-4-methoxydihydrochalcone. Researchers often study these components through various preparations, such as crude extracts and methanol extracts. These studies are particularly focused on the plant's ability to mitigate the effects of Reactive Oxygen Species. Through the analysis of methanolic extract samples, the therapeutic potential of this species continues to be explored.
- Synonyms
- Draco Cinnabari
- Common names
- Not available
- Family
- Asparagaceae
- Distribution
- Not available
- Plant Parts
- Not available
Classification
Common Names
Dracaena cinnabari is a remarkable species known widely by its evocative English name, the Dragon's Blood Tree. Depending on the region and language, this unique plant carries several distinct titles, such as the German Drachenblutbaum or the Drachenpalme. In Italian, it is affectionately referred to as the Albero del drago di Socotra, highlighting its specific geographic origins. French speakers may also recognize it by the name Dragonnier de Socotra. Regardless of which common name is used, the tree remains one of the most iconic symbols of its native landscape.
Sources: Catalogue of Life (COL)
Synonyms
Dracaena cinnabari is a remarkable species widely recognized for its unique umbrella-like canopy. In botanical literature, this distinctive plant is also frequently referred to by its synonym, Draco cinnabari. Understanding these nomenclature variations is essential for researchers studying its specific ecological niche. Whether labeled under either name, the species remains a vital component of its native landscape. Consequently, recognizing both terms ensures clarity when discussing this iconic dragon tree.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Dracaena cinnabari belongs to the vast kingdom Plantae, marking its place among the diverse life forms of our world. Within this kingdom, it is classified under the class Equisetopsida and falls into the order Asparagales. This botanical specimen is a distinguished member of the family Asparagaceae, showcasing unique evolutionary traits. Specifically, it is nested within the genus Dracaena, which defines its morphological characteristics. Together, these taxonomic relationships provide a clear scientific roadmap of its biological heritage.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Asparagales |
| Family | Asparagaceae |
| Genus | Dracaena |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Dracaena cinnabari is a distinctive species primarily found within the unique ecosystems of Northeast Tropical Africa. This remarkable plant is most famously associated with the isolated island of Socotra, where it defines the landscape. Its specific distribution makes it a cornerstone of the local environment, providing essential shade and structure. Because it is so geographically concentrated, the species is inextricably linked to its specific African habitats. Understanding its range is crucial for the continued preservation of this iconic botanical treasure.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Dracaena cinnabari grows in a distinct tree form that allows it to stand as a self-supporting organism in its natural habitat. This unique botanical structure enables the species to reach a maximum height of approximately 9 meters. As a sturdy and well-defined tree, it maintains a commanding presence within its ecosystem.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Compounds
Dracaena cinnabari is an endemic tropical plant that serves as a rich source of diverse polyphenolic compounds. Research has successfully isolated a series of homoisoflavonoids and chalcones from this species for pharmacological study. Among these constituents, specific flavonoids like 2-hydroxychalcone have demonstrated the ability to inhibit CYP1A enzymes with an efficacy comparable to quercetin. Furthermore, certain homoisoflavonoids found within the plant exhibit potent antioxidant activity by preventing the peroxidation of microsomal lipids. These findings highlight the significant chemoprotective potential held by the chemical profile of Dracaena cinnabari.
Conditions
Dracaena cinnabari demonstrates significant therapeutic potential, such as its ability to treat tongue carcinogenesis induced by 4-nitroquinolone-1-oxide through the induction of apoptosis. The plant's red resin contains chalcone derivatives that effectively treat Hepatitis B virus (HBV) infection by inhibiting HBsAg production. In the context of gastrointestinal health, its gum resin is recognized in traditional medicine as a potential remedy for treating inflammatory bowel disease (IBD). Additionally, Dragon's Blood can treat UVA and UVB irritating skin reactions when applied via biocompatible hydrogel patches. Finally, it provides protection in a UVB-irradiated HaCaT cell phototoxicity model by increasing cell viability and reducing reactive oxygen species.
Preparations
Dracaena cinnabari is prepared as crude extracts to demonstrate significant antimicrobial activity and properties that support its folkloric use. This plant is also prepared as gum resin, though there are currently insufficient studies to confirm its specific benefits in treating inflammatory bowel disease. Furthermore, Dracaena cinnabari is prepared as methanol extracts to investigate its antiviral activity against the influenza virus. The species is also prepared as a methanolic extract for bioassay-guided fractionation to isolate chalcone derivatives. These various preparations allow researchers to explore the medicinal potential of the dragon's blood tree.